| News
Basel impresses with quality of living
14.03.2017
Basel is among the top ten cities with the highest quality of living in the world, according to the latest Mercer Quality of Living ranking. 2017 marks the first year that Basel was included in the ranking.
Panorama Basel (img: Andreas Zimmermann)
Basel’s debut in Mercer’s global index evaluating quality of living was a resounding success. Expats handed out top grades to the city, which tied with Sydney, Australia, for tenth place. Vienna once again came in first place, followed by Zurich, Auckland, Munich and Vancouver. With Geneva (8th place) and Bern (14th), two other Swiss cities made it among the top 20.
A total of 231 large cities were compared in this year’s ranking, which analyses and compares living conditions according to 39 factors, such as political and social environment, economic conditions, and natural environment. Factors like health and education are also taken into consideration.
The annual survey is conducted to enable multinational companies and other organisations compare different cities when looking at where to place employees for international assignments.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
BLKB supporting startups in Basel region
Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...
Read More
BioVersys receives funding in the fight against tuberculosis
The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...
Read More
Biosynex takes up residence in Delémont
The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has...
Read More
Novartis Campus opening further
Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...
Read More
docdok.health increases safety of coronavirus vaccinations
The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...
Read More
Hemex attracts Swiss investors
A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...
Read More
Rhizen drug secures approval in the USA
The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib. Basel biotech Rhizen has discovered...
Read More
Novaremed secures US$50 million
Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed will use this financing to...
Read More
Axtria driving growth from Basel
The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry...
Read More
Technologiepark Basel celebrates its role as a driver of innovation
The Technologiepark Basel will be ten years old in 2021. Over the past decade, it has supported many startups and...
Read More
